USPTO 2015–2025 USPTO PatentsView US Corporation

RMO, Inc.

USPTO PatentsView assignee record - 17 granted patents across 2 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61C (DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene).

RSS updates for this company

The verdict

According to USPTO PatentsView, RMO ranks #17,127 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 2 technology areas.

#17,127
of 49,997 US assignees by volume
16th percentile
by Innovation Score (24.8/100)
16.4
avg claims per patent
-87%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17127 · US Corporation #17,127 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 17 grants
  • MID-PACK #17,127/49,997
  • PHOTO-FINISH Regenera Pharma
  • CPC-NARROW A61C · 2 areas
  • INNOV-THIN 24.8/100
  • CLAIMS-RICH 16.4 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -87% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Regenera Pharma Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How RMO’s 24.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around RMO

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows RMO's Innovation Score is 24.8/100 (16th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for RMO?

Each dot is one of RMO’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). RMO’s own 16.4 claims/patent is ABOVE the 13.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

RMO vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 16.916.91717.1 0510152025 Granted patents (volume) Avg claims / patent Regenera Pharma Ltd. - 17, 15.88Regenera PharmaRenu Robotics Corp. - 17, 19.94Renu RoboticsRicoh Electronic Devices Co., Ltd. - 17, 9Ricoh DevicesRight Group Central Co., Ltd. - 17, 7.29Right Group Centr…Roam Robotics Inc. - 17, 18.06Roam RoboticsRoberto Coin S.P.A. - 17, 1Roberto Coin S P ARoswell Canada Inc. - 17, 13Roswell CanadaRothenberger AG - 17, 13.35RothenbergerRMO, Inc. - 17, 16.41RMO
RMO vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where RMO's grants concentrate

RMO, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 76.5% of grants classified under A61C (DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene). Peak complete grant year is 2015 (5 grants) versus a trough of 2 in 2020. By volume, RMO sits between Regenera Pharma Ltd. and Rothenberger AG.

Who files at RMO's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows RMO holds 17 patents at rank #17,119, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near RMO

By rank, the assignees closest to #17,119 in granted patent volume.

Leaders in A61C (Dentistry)

Other assignees with the most granted patents in RMO's primary technology class.

RMO's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 16th percentile higher than 16% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

123456 20152017201820192020 2
USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
RMO, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 29.4%
2017 3 17.6%
2018 4 23.5%
2019 3 17.6%
2020 2 11.8%

Which technologies does RMO, Inc. patent most?

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

RMO, Inc.'s patent record in context - here's where to go next.

  • RMO, Inc.'s lead technology class is A61C (DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene), 76.5% of its portfolio - see every assignee active in that class. Explore A61C
  • Ranked #17,127 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare RMO, Inc. against Regenera Pharma Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 24.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.